Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95713502 | 9571350 | 2 | F | 20160820 | 20131001 | 20160902 | EXP | US-RANBAXY-2013US-73594 | RANBAXY | 65.00 | YR | F | Y | 60.77000 | KG | 20160902 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95713502 | 9571350 | 1 | PS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25 MG, DAILY | Y | 40810 | 25 | MG | |||||||
| 95713502 | 9571350 | 2 | SS | IRBESARTAN. | IRBESARTAN | 1 | Unknown | 300 MG, DAILY | U | 0 | 300 | MG | |||||||
| 95713502 | 9571350 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | 20 MG, DAILY | U | 0 | 20 | MG | |||||||
| 95713502 | 9571350 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | 88 ?G, DAILY | U | U | 0 | 88 | UG | ||||||
| 95713502 | 9571350 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | 50 MG, BID | U | U | 0 | 50 | MG | Q12H | |||||
| 95713502 | 9571350 | 6 | C | Atorvastatin | ATORVASTATIN | 1 | Unknown | 10 MG, DAILY | U | U | 0 | 10 | MG | ||||||
| 95713502 | 9571350 | 7 | C | DIAZEPAM. | DIAZEPAM | 1 | Unknown | 5 MG, TID | U | U | 0 | 5 | MG | Q8H | |||||
| 95713502 | 9571350 | 8 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | UNK, PRN | U | U | 0 | ||||||||
| 95713502 | 9571350 | 9 | C | VIVELLE-DOT | ESTRADIOL | 1 | Unknown | U | U | 0 | TRANSDERMAL PATCH |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 95713502 | 9571350 | 1 | Product used for unknown indication |
| 95713502 | 9571350 | 2 | Product used for unknown indication |
| 95713502 | 9571350 | 3 | Product used for unknown indication |
| 95713502 | 9571350 | 4 | Product used for unknown indication |
| 95713502 | 9571350 | 5 | Product used for unknown indication |
| 95713502 | 9571350 | 6 | Product used for unknown indication |
| 95713502 | 9571350 | 7 | Product used for unknown indication |
| 95713502 | 9571350 | 8 | Product used for unknown indication |
| 95713502 | 9571350 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 95713502 | 9571350 | LT |
| 95713502 | 9571350 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 95713502 | 9571350 | Hyponatraemia | |
| 95713502 | 9571350 | Neurological symptom |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |